Suppr超能文献

血小板α-颗粒和质膜共有两种新成分:CD9和血小板内皮细胞黏附分子-1(PECAM-1)。

Platelet alpha-granule and plasma membrane share two new components: CD9 and PECAM-1.

作者信息

Cramer E M, Berger G, Berndt M C

机构信息

Inserm U.348, Hôpital Lariboisière, Paris, France.

出版信息

Blood. 1994 Sep 15;84(6):1722-30.

PMID:8080982
Abstract

CD9 (p24) and PECAM1 (CD31) antigens are well-defined components of the platelet plasma membrane. Both are integral glycoproteins (GPs) implicated in the adhesive and aggregative properties of human platelets. In the present report, we have investigated their subcellular localization using immunoelectron microscopy. The monospecificity of the two polyclonal antibodies used was confirmed by immunoblotting. On normal resting platelets, immunolabeling for CD9 and PECAM1 was found lining the plasma membrane and the luminal face of the open canalicular system. Some labeling was also consistently found on the alpha-granule limiting membrane. This was confirmed by double labeling experiments in which fibrinogen and von Willebrand factor (vWF) were used as alpha-granule markers. CD9 and PECAM-1 were found lining the membrane of the same granules that contained fibrinogen and vWF in their matrix. CD9 and PECAM-1 thus appear to have an intracellular distribution identical to GPIIb-IIIa, a major aggregation platelet receptor. To rule out a cross-reactivity of the two polyclonal antibodies with GPIIb/IIIa, we studied PECAM1 and CD9 expression on the platelets from a patient with type I Glanzmann's thrombasthenia whose platelets are devoid of GPIIb/IIIa. The same pattern of labeling was observed for both antigens as for normal platelets. Normal platelets were further observed after stimulation by agonists that either fail to induce (ADP) or induce granule secretion (thrombin). After treatment with ADP, platelets changed shape and centralized their granules; the plasma membrane immunolabeling remained unchanged; and gold particles were still found decorating the periphery of the centralized alpha-granules. After thrombin treatment, alpha-granules fused with the platelet membrane and secretion occurred. A significant increase of labeling was then observed on the platelet surface. From these results we conclude that the alpha-granule membrane contains two additional receptors in common with the plasma membrane. This suggests that alpha-granule membrane receptors may originate from a dual mechanism: direct targeting from the Golgi complex in megakaryocytes (for alpha-granule-specific receptors such as P-selectin) or by endocytosis from the plasma membrane (for proteins distributed in the two compartments).

摘要

CD9(p24)和PECAM1(CD31)抗原是血小板质膜的明确组成成分。二者均为整合糖蛋白(GP),与人类血小板的黏附及聚集特性有关。在本报告中,我们利用免疫电子显微镜研究了它们的亚细胞定位。通过免疫印迹证实了所使用的两种多克隆抗体的单特异性。在正常静息血小板上,发现CD9和PECAM1的免疫标记位于质膜和开放管道系统的腔面。在α颗粒的限制膜上也始终能发现一些标记。这通过双标记实验得以证实,其中纤维蛋白原和血管性血友病因子(vWF)被用作α颗粒标记物。发现CD9和PECAM - 1位于含有纤维蛋白原和vWF的同一颗粒的膜上。因此,CD9和PECAM - 1似乎具有与主要聚集血小板受体GPIIb - IIIa相同的细胞内分布。为排除这两种多克隆抗体与GPIIb / IIIa的交叉反应性,我们研究了一名I型Glanzmann血小板无力症患者血小板上PECAM1和CD9的表达,该患者的血小板缺乏GPIIb / IIIa。两种抗原的标记模式与正常血小板相同。在用未能诱导(ADP)或诱导颗粒分泌(凝血酶)的激动剂刺激正常血小板后进行了进一步观察。用ADP处理后,血小板改变形状并使颗粒集中;质膜免疫标记保持不变;并且仍能发现金颗粒装饰集中的α颗粒的周边。用凝血酶处理后,α颗粒与血小板膜融合并发生分泌。然后在血小板表面观察到标记显著增加。从这些结果我们得出结论,α颗粒膜含有另外两种与质膜共有的受体。这表明α颗粒膜受体可能源于双重机制:巨核细胞中从高尔基体复合体直接靶向(针对α颗粒特异性受体,如P - 选择素)或通过从质膜内吞(针对分布在两个区室的蛋白质)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验